Exousia Bio, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Exousia Bio, Inc. reported Cash And Cash Equivalents At Carrying Value of $7.9 thousand for the year ending 2023.

  • Exousia Bio, Inc. showed a decrease of -22.3% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from Exousia Bio, Inc.'s annual report (Form 10-K), filed with the SEC on September 1, 2023.
  • XBRL data for this metric is available from 2022 to 2023 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2023: $7.9 thousand | Fiscal year 2022: $10.1 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: